OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects
Benjamin Berger, Rüdiger Kornberger, Jasper Dingemanse
European Neuropsychopharmacology (2021) Vol. 51, pp. 90-104
Closed Access | Times Cited: 12
Benjamin Berger, Rüdiger Kornberger, Jasper Dingemanse
European Neuropsychopharmacology (2021) Vol. 51, pp. 90-104
Closed Access | Times Cited: 12
Showing 12 citing articles:
Daridorexant: First Approval
Anthony Markham
Drugs (2022) Vol. 82, Iss. 5, pp. 601-607
Open Access | Times Cited: 56
Anthony Markham
Drugs (2022) Vol. 82, Iss. 5, pp. 601-607
Open Access | Times Cited: 56
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Serotonergic Mechanisms in Proteinoid-Based Protocells
Panagiotis Mougkogiannis, Andrew Adamatzky
ACS Chemical Neuroscience (2025)
Open Access
Panagiotis Mougkogiannis, Andrew Adamatzky
ACS Chemical Neuroscience (2025)
Open Access
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Daridorexant for the Treatment of Insomnia
Christopher L. Robinson, Rajesh Supra, Evan Downs, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 15
Christopher L. Robinson, Rajesh Supra, Evan Downs, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 15
Synergistic antidepressant effects of citalopram and SB-334867 in the REM sleep-deprived mice: Possible role of BDNF
Naghmeh Saadati, Maryam Bananej, Fatemeh Khakpai, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 219, pp. 173449-173449
Closed Access | Times Cited: 12
Naghmeh Saadati, Maryam Bananej, Fatemeh Khakpai, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 219, pp. 173449-173449
Closed Access | Times Cited: 12
Daridorexant for the treatment of insomnia disorder: findings and implications
Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1749-1761
Closed Access | Times Cited: 12
Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1749-1761
Closed Access | Times Cited: 12
A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
Wojciech Ziemichód, Karolina Grabowska, Antonina Kurowska, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6041-6041
Open Access | Times Cited: 9
Wojciech Ziemichód, Karolina Grabowska, Antonina Kurowska, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6041-6041
Open Access | Times Cited: 9
Daridorexant: Comprehensive Review of A New Oral Agent for the Treatment of Insomnia
Juliane Park, Kandon P. Render, Drew W. Cates
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 5
Juliane Park, Kandon P. Render, Drew W. Cates
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 5
Daridorexant, an Orexin Receptor Antagonist for the Management of Insomnia
Jadwiga Najib, Yuliana Toderika, Lorena Dima
American Journal of Therapeutics (2023) Vol. 30, Iss. 4, pp. e360-e368
Closed Access | Times Cited: 3
Jadwiga Najib, Yuliana Toderika, Lorena Dima
American Journal of Therapeutics (2023) Vol. 30, Iss. 4, pp. e360-e368
Closed Access | Times Cited: 3
A comprehensive review of Dual Orexin Receptor Antagonist (DORA), Daridorexant: Novel drug for sleep and related disorders
Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
International journal of life sciences, biotechnology and pharma research. (2024) Vol. 13, Iss. 6, pp. 20-29
Open Access
Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
International journal of life sciences, biotechnology and pharma research. (2024) Vol. 13, Iss. 6, pp. 20-29
Open Access
The effects of citalopram, SB-334867 and orexin-1, alone or in various combinations, on the anxiogenic-like effects of REM sleep deprivation in male mice
Naghmeh Saadati, Maryam Bananej, Fatemeh Khakpai, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 8, pp. 559-566
Closed Access | Times Cited: 1
Naghmeh Saadati, Maryam Bananej, Fatemeh Khakpai, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 8, pp. 559-566
Closed Access | Times Cited: 1
